🇺🇸 FDA
Patent

US 9938258

Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof

granted A61PA61P35/00

Quick answer

US patent 9938258 (Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof) held by Karyopharm Therapeutics Inc. expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Karyopharm Therapeutics Inc.
Grant date
Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P35/00